Compositions comprising a nutritionally or pharmaceutically effective dosage of an extract of Salvia officinalis and an acceptable carrier are provided. The compositions show particular potential in the treatment of age-related pathologies in humans or animals.

Summary Chronos Therapeutics Ltd Chronos is a research company that offers drug discovery and development services. The company offers research and development, drug discovery, lead optimization, preclinical efficacy, IND enabling, screening, ...

You need to enable JavaScript to run this app

You need to enable JavaScript to run this app

March 19, 2024 - We cannot provide a description for this page right now

Chrono Therapeutics is a pharmaceutical company with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery that offers real-time behavioral support. Chrono’s executive leadership combines years of professional ...

The companies will work together on integrated drug discovery - medicinal and computational chemistry, biology and DMPK - to optimise Chronos’ selective orexin 1 antagonists that have shown promise in treating addiction.

Chronos Therapeutics Limited operates as a pharmaceutical company. The Company discovers and develops chronos therapeutics drugs for neurodegenerative diseases.

You need to enable JavaScript to run this app · Loading

Chronos Therapeutics is a drug development company focused on the development of drugs for the treatment of age-related diseases.

Chronos Therapeutics drug development scheme focuses in two main areas: - Repositioning FDA approved drugs. - Screening, discovery and development of novel proprietary drug candidates.

Innovative membership organization offering services to the international sector. Instant access to high quality CV’s, procurement notices shortlist and awards information

Chronos Therapeutics Ltd is a privately held biotechnology company focused on diseases of ageing, brain and nervous system disorders. Chronos has a dedicated laboratory in Oxford which screens for activity of drugs in brain disease through its proprietary platform, ChronoscreenTM.

Chronos Therapeutics is a drug development company focused on the development of drugs for the treatment of age-related diseases.

Chronos Therapeutics was founded in 2009.

June 17, 2025 - ... Chronos Therapeutic is a drug discovery and development company focusing on - Repositioning FDA approved drugs, screening, discovery and development of novel proprietary drug candidates.

January 1, 2018 - Methodology: CHRONOS is a liquid biopsy-driven trial to assess the efficacy of rechallenging with panitumumab (PAN) mCRC patients with ct-DNA-proven RAS-mediated acquired resistance.

October 7, 2025 - The five-year survival of the severe grades is 5%. The data generated for SFX-01 in standard preclinical models and orthotopic models (where glioma cells are implanted in brain tissue representing a more disease-relevant model) show tumour shrinkage and significantly extended survival times. SFX-01 was also found to potentiate (i.e. substantially increase) the therapeutic effect of radiotherapy in these models.

Chronos is a CNS specialist company with a high concentration of expertise in both degenerative and behavioural diseases of the brain and nervous system. What we do: Chronos is an Oxford-based biotechnology company operating a semi-virtual ...

This chapter summarizes the current state of the art of chronotherapeutics, based on the consensus report of a committee convened by the International Society for Affective Disorders (ISAD) (Wirz-Justice et al., 2005). This has been followed up by the publication of a manual providing treatment guidelines for clinical practice (Wirz-Justice et al., 2009a), and a non-profit website Center for Environmental Therapeutics, www.cet.org.